Well the Chairman/CEO of Applied Biosystems isn’t the only one dumping his stock — we have just learned that the company’s CFO, Dennis Winger, is doing the same thing. Winger is selling nearly $11 million in stock before the company merges with Invitrogen.

Unlike Applied’s CEO however, Mr. Winger is not on the list of executives who will be resigning from the company. Since Applied hasn’t issued any statements, we’re forced to speculate about the trading activity. Are these two high executives taking advantage of stock bonuses or are they using the merger as an excuse to unload shares? Either way, it doesn’t speak much for their faith in the combined company…

[Finviz] Dennis Winger’s Insider Trading Activity